|
Re: trying to making sense
|
7
|
Resverlogix Corp.
|
Mar 09, 2022 11:55AM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
7
|
Resverlogix Corp.
|
Feb 20, 2022 12:06PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
7
|
Resverlogix Corp.
|
Aug 13, 2023 12:51PM
|
|
Re: Will we see a Zenith deal before years end???
|
7
|
Zenith Epigenetics
|
Nov 16, 2018 02:28PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 27, 2022 06:39PM
|
|
Re: Another Exempt Distribution -2022-06-02
|
7
|
Resverlogix Corp.
|
Jun 08, 2022 11:33AM
|
|
Re: Random thoughts in the vacuum of information
|
7
|
Resverlogix Corp.
|
Jul 03, 2024 12:52PM
|
|
Re: from Sarah yesterday afternoon...
|
7
|
Resverlogix Corp.
|
Jan 12, 2022 11:18AM
|
|
Re: Voting you shares.
|
7
|
Resverlogix Corp.
|
Jun 06, 2023 11:05AM
|
|
Trial started
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 07:49AM
|
|
Re: Did you notice?
|
7
|
Resverlogix Corp.
|
May 26, 2022 11:31AM
|
|
Re: Apabetalone MOA diagram
|
7
|
Resverlogix Corp.
|
Sep 29, 2019 12:30PM
|
|
Re: Local TV Station Global Calgary
|
7
|
Resverlogix Corp.
|
Mar 12, 2021 10:53AM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
7
|
Zenith Epigenetics
|
Sep 27, 2024 12:07PM
|
|
Re: As we finish another brutal year as retail shareholders....
|
7
|
Resverlogix Corp.
|
Dec 30, 2021 10:26AM
|
|
Re: Still no trial.....wow
|
7
|
Resverlogix Corp.
|
Apr 30, 2021 09:31AM
|
|
Re: The way the trading has gone the past few days....
|
6
|
Resverlogix Corp.
|
Jul 19, 2018 02:37PM
|
|
Re: Anacetrapib Officially Bites the Dust
|
6
|
Resverlogix Corp.
|
Oct 26, 2017 05:08PM
|
|
Congrats
|
6
|
Resverlogix Corp.
|
Jul 25, 2017 11:39AM
|
|
Re: The costs of Long Covid
|
6
|
Resverlogix Corp.
|
Feb 08, 2022 01:51PM
|
